Literature DB >> 19178513

Cerebral white matter hyperintensity is mainly associated with hypertension among the components of metabolic syndrome in Koreans.

Hoon Sung Choi1, Young Min Cho, Jin Hwa Kang, Chan Soo Shin, Kyong Soo Park, Hong Kyu Lee.   

Abstract

BACKGROUND: Cerebral white matter hyperintensity (WMH) is a common abnormality in brain magnetic resonance imaging (MRI) and is known to be associated with ischaemic stroke. Previous studies revealed that the risk factors for cerebral WMH were age, female gender, hypertension and diabetes. In this study we examined the association between cerebral WMH and metabolic syndrome, a cluster of hypertension, glucose intolerance, abdominal obesity and dyslipidaemia. METHODS AND
RESULTS: We reviewed the results of brain MRI of 5498 subjects who underwent routine check-ups including laboratory tests at the Seoul National University Health Care System. Among the subjects who met the inclusion criteria (n = 5104), 1693 (33.2%) had cerebral WMH. They were characterized by old age, female predominance, higher body mass index (BMI), larger waist circumference, higher blood pressure, higher fasting plasma glucose level, and higher haemoglobin A1c (HbA1c). In multivariate analyses, age, female gender and hypertension were the independent risk factors for cerebral WMH. Metabolic syndrome was associated with cerebral WMH after adjusting for age and gender [odds ratio (OR) 1.20, 95% confidence interval (CI) 1.04-1.39, P = 0.014]. Among the components of metabolic syndrome, hypertension was independently associated with cerebral WMH (OR 1.20, 95% CI 1.05-1.38, P = 0.007).
CONCLUSION: Age, female gender and hypertension were risk factors for cerebral WMH in the Korean population. Cerebral WMH was also associated with metabolic syndrome; however, metabolic syndrome offered no advantage over hypertension alone in predicting cerebral WMH.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19178513     DOI: 10.1111/j.1365-2265.2008.03444.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  7 in total

1.  Visceral obesity is associated with white matter hyperintensity and lacunar infarct.

Authors:  K W Kim; H Seo; M-S Kwak; D Kim
Journal:  Int J Obes (Lond)       Date:  2017-01-20       Impact factor: 5.095

2.  Higher intraocular pressure is associated with leukoaraiosis among middle-aged and elderly Koreans without glaucoma or dementia.

Authors:  B-J Park; J-K Kim; Y-J Lee
Journal:  Eye (Lond)       Date:  2014-03-28       Impact factor: 3.775

3.  Obstructive sleep apnea as a risk factor for cerebral white matter change in a middle-aged and older general population.

Authors:  Hyun Kim; Chang-Ho Yun; Robert Joseph Thomas; Seung Hoon Lee; Hyung Suk Seo; Eo Rin Cho; Seung Ku Lee; Dae Wui Yoon; Sooyeon Suh; Chol Shin
Journal:  Sleep       Date:  2013-05-01       Impact factor: 5.849

4.  Brain morphometric correlates of metabolic variables in HIV: the CHARTER study.

Authors:  S L Archibald; J A McCutchan; C Sanders; T Wolfson; T L Jernigan; R J Ellis; B M Ances; A C Collier; J C McArthur; S Morgello; D M Simpson; C Marra; B B Gelman; D B Clifford; I Grant; C Fennema-Notestine
Journal:  J Neurovirol       Date:  2014-09-17       Impact factor: 2.643

5.  Age-related white matter changes.

Authors:  Yun Yun Xiong; Vincent Mok
Journal:  J Aging Res       Date:  2011-08-23

6.  Metabolic syndrome alters relationships between cardiometabolic variables, cognition and white matter hyperintensity load.

Authors:  E Alkan; T P Taporoski; A Sterr; M von Schantz; H Vallada; J E Krieger; A C Pereira; R Alvim; A R V R Horimoto; S Pompéia; A B Negrão; S L H Evans
Journal:  Sci Rep       Date:  2019-03-13       Impact factor: 4.379

7.  Inverse relationship between apolipoprotein A-I and cerebral white matter lesions: a cross-sectional study in middle-aged and elderly subjects.

Authors:  Ze-Gang Yin; Ling Li; Min Cui; Shi-Ming Zhou; Ming-Ming Yu; Hua-Dong Zhou
Journal:  PLoS One       Date:  2014-05-12       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.